These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 21208583

  • 1. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
    Vitiello B, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes TL, DeBar L, Lynch F, Dickerson J, Strober M, Suddath R, McCracken JT, Spirito A, Onorato M, Zelazny J, Porta G, Iyengar S, Brent DA.
    J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
    [Abstract] [Full Text] [Related]

  • 2. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
    Emslie GJ, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, Asarnow JR, Spirito A, Birmaher B, Ryan N, Kennard B, DeBar L, McCracken J, Strober M, Onorato M, Zelazny J, Keller M, Iyengar S, Brent D.
    Am J Psychiatry; 2010 Jul; 167(7):782-91. PubMed ID: 20478877
    [Abstract] [Full Text] [Related]

  • 3. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
    Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, Vitiello B, Ritz L, Iyengar S, Abebe K, Birmaher B, Ryan N, Kennard B, Hughes C, DeBar L, McCracken J, Strober M, Suddath R, Spirito A, Leonard H, Melhem N, Porta G, Onorato M, Zelazny J.
    JAMA; 2008 Feb 27; 299(8):901-913. PubMed ID: 18314433
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.
    Woldu H, Porta G, Goldstein T, Sakolsky D, Perel J, Emslie G, Mayes T, Clarke G, Ryan ND, Birmaher B, Wagner KD, Asarnow JR, Keller MB, Brent D.
    J Am Acad Child Adolesc Psychiatry; 2011 May 27; 50(5):490-8. PubMed ID: 21515198
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM.
    Clin Ther; 2002 Jul 27; 24(7):1194-200. PubMed ID: 12182262
    [Abstract] [Full Text] [Related]

  • 6. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    Health Technol Assess; 2008 May 27; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [Abstract] [Full Text] [Related]

  • 7. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
    McMakin DL, Olino TM, Porta G, Dietz LJ, Emslie G, Clarke G, Wagner KD, Asarnow JR, Ryan ND, Birmaher B, Shamseddeen W, Mayes T, Kennard B, Spirito A, Keller M, Lynch FL, Dickerson JF, Brent DA.
    J Am Acad Child Adolesc Psychiatry; 2012 Apr 27; 51(4):404-11. PubMed ID: 22449646
    [Abstract] [Full Text] [Related]

  • 8. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR, Huang H, Thase ME.
    J Clin Psychiatry; 2001 Nov 27; 62(11):869-77. PubMed ID: 11775046
    [Abstract] [Full Text] [Related]

  • 9. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
    Hilton RC, Rengasamy M, Mansoor B, He J, Mayes T, Emslie GJ, Porta G, Clarke GN, Wagner KD, Birmaher B, Keller MB, Ryan N, Shamseddeen W, Asarnow JR, Brent DA.
    J Am Acad Child Adolesc Psychiatry; 2013 May 27; 52(5):482-92. PubMed ID: 23622849
    [Abstract] [Full Text] [Related]

  • 10. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May 27; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 11. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
    Lynch FL, Dickerson JF, Clarke G, Vitiello B, Porta G, Wagner KD, Emslie G, Asarnow JR, Keller MB, Birmaher B, Ryan ND, Kennard B, Mayes T, DeBar L, McCracken JT, Strober M, Suddath RL, Spirito A, Onorato M, Zelazny J, Iyengar S, Brent D.
    Arch Gen Psychiatry; 2011 Mar 27; 68(3):253-62. PubMed ID: 21383263
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar 27; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 13. Substance use and the treatment of resistant depression in adolescents.
    Goldstein BI, Shamseddeen W, Spirito A, Emslie G, Clarke G, Wagner KD, Asarnow JR, Vitiello B, Ryan N, Birmaher B, Mayes T, Onorato M, Zelazny J, Brent DA.
    J Am Acad Child Adolesc Psychiatry; 2009 Dec 27; 48(12):1182-92. PubMed ID: 19858762
    [Abstract] [Full Text] [Related]

  • 14. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M, Tharmanathan P, Volz HP, Moeller HJ, Freemantle N.
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr 27; 259(3):172-85. PubMed ID: 19165525
    [Abstract] [Full Text] [Related]

  • 15. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
    Asarnow JR, Emslie G, Clarke G, Wagner KD, Spirito A, Vitiello B, Iyengar S, Shamseddeen W, Ritz L, Birmaher B, Ryan N, Kennard B, Mayes T, DeBar L, McCracken J, Strober M, Suddath R, Leonard H, Porta G, Keller M, Brent D.
    J Am Acad Child Adolesc Psychiatry; 2009 Mar 27; 48(3):330-339. PubMed ID: 19182688
    [Abstract] [Full Text] [Related]

  • 16. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M, STAR*D Study Team.
    N Engl J Med; 2006 Mar 23; 354(12):1231-42. PubMed ID: 16554525
    [Abstract] [Full Text] [Related]

  • 17. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, Reynolds CF.
    J Clin Psychiatry; 2004 Dec 23; 65(12):1634-41. PubMed ID: 15641868
    [Abstract] [Full Text] [Related]

  • 18. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM, Rush AJ, Koslow SH, Wisniewski SR, Cooper NJ, Nemeroff CB, Schatzberg AF, Gordon E.
    Trials; 2011 Jan 05; 12():4. PubMed ID: 21208417
    [Abstract] [Full Text] [Related]

  • 19. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA, Emslie GJ, Clarke GN, Asarnow J, Spirito A, Ritz L, Vitiello B, Iyengar S, Birmaher B, Ryan ND, Zelazny J, Onorato M, Kennard B, Mayes TL, Debar LL, McCracken JT, Strober M, Suddath R, Leonard H, Porta G, Keller MB.
    Am J Psychiatry; 2009 Apr 05; 166(4):418-26. PubMed ID: 19223438
    [Abstract] [Full Text] [Related]

  • 20. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML, Garfield LD, Teitelbaum S, Civitelli R, Mulsant BH, Reynolds CF, Dixon D, Doré P, Lenze EJ.
    Osteoporos Int; 2013 May 05; 24(5):1741-9. PubMed ID: 23358607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.